Prof Research published a new report on prefilled syringes drug market. It presents the largest 13 manufacturers in prefilled syringes drug Market. The report is a professional and in-depth study of the current state of the global prefilled syringes drug market. The report provides key statistics on the market of prefilled syringes drug. This report covers 1 product: prefilled syringes drug. It is a valuable source of guidance and direction for companies and individuals interested in prefilled syringes drug industry.

The global prefilled syringes drug market was valued to be 229,026 million USD in 2021. The prefilled syringes drug production value is anticipated to have growth with a CAGR of 4.91% in the coming years to reach 305,372 million USD in 2027.

Pfizer is the largest manufacturer of prefilled syringes drug in the world, and it has a market share of 18.6% in value. Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

AbbVie is the second-largest manufacturer of prefilled syringes drug in the world, and it has a market share of 11.0% in value. AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies.

Sinovac Biotech is the third largest manufacturer of prefilled syringes drug in the world, and it has a market share of 8.5% in value. Sinovac Biotech Ltd. (Sinovac) is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps.

Novo Nordisk is the fourth largest manufacturer of prefilled syringes drug in the world, and it has a market share of 7.9% in value. Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals.